Pyxis Oncology, Inc. · NASDAQ:PYXS
Coastlands Capital LP reported a 5.42% stake in Pyxis Oncology, Inc. (Schedule 13G)
Event Oct 1, 2026 · Filed Oct 5, 2026
Coastlands Capital LP reported a 5.42% stake in Pyxis Oncology, Inc., 6,448,907 shares, as a passive investor on Oct 1, 2026. Filed Oct 5, 2026 (Schedule 13G).
- Stake
- 5.42%
- Shares
- 6,448,907
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Coastlands Capital LP | 5.42% | 6,448,907 |
| Coastlands Capital Partners LP | 5.42% | 6,448,907 |
| Coastlands Capital GP LLC | 5.42% | 6,448,907 |
| Coastlands Capital LLC | 5.42% | 6,448,907 |
| Matthew D. Perry | 5.42% | 6,448,907 |
Source
Related
- Pyxis Oncology, Inc.
- Coastlands Capital LP
- Pyxis Oncology, Inc. shareholders
- Schedule 13G/A · GordonMD Global Investments LP · Oct 9, 2026
- Form 4 · GordonMD Global Investments LP · Oct 2, 2026
- Schedule 13G/A · GordonMD Global Investments LP · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Jul 10, 2026
- Form 4 · Dupont Jakob · Jul 2, 2026